Navigation Links
Second-hand smoke increases risk of invasive meningococcal disease in children
Date:12/9/2012

The dangers of second-hand smoke (passive smoking) on children continue to become ever more apparent. A new study published in BioMed Central's open access journal BMC Public Health shows that second hand smoke and foetal exposure due to maternal smoking while pregnant significantly increase the risk of invasive meningococcal disease.

Invasive meningococcal disease, a major cause of bacterial meningitis, can also cause severe illness when bacteria, such as Neisseria meningitidi, invade the blood, lungs or joints. Menigococcal disease is particularly prevalent in children and young adults, and nearly 1 in 20 affected individuals will die despite medical attention. 1 in 6 will be left with a severe disability, including neurological and behavioural disorders.

Several studies suggest that exposure to second hand smoke (passive smoking) may be involved in meningococcal disease. Researchers Dr Rachael Murray and Dr Jo Leonardi-Bee from the UK Centre for Tobacco Control Studies, University of Nottingham performed a systematic review of 18 studies which all looked at the effects of passive smoking on the risk of invasive meningococcal disease in children.

The results showed that being exposed to second-hand smoke at home doubled the risk of invasive meningococcal disease. For children under five this risk was even higher, and for children born to mothers who smoked during pregnancy the risk increased to three times that of children born to non-smoking households

Translating these results Rachael Murray explained, "We estimate that an extra 630 cases of childhood invasive meningococcal disease every year are directly attributable to second hand smoke in the UK alone. While we cannot be sure exactly how tobacco smoke is affecting these children, the findings from this study highlight consistent evidence of the further harms of smoking around children and during pregnancy, and thus parents and family members should be
'/>"/>

Contact: Hilary Glover
44-020-319-22370
BioMed Central
Source:Eurekalert

Page: 1 2

Related biology news :

1. Rapid response in cases of smoke poisoning
2. Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
3. OHSU study shows that a molecule critical to nerve cells increases drammatically during hypertension
4. Cell Transplantation reports islet cell advancement increases impact on transplantation
5. Climate change increases stress, need for restoration on grazed public lands
6. Chronic kidney disease increases risk of death at all ages
7. HIV treatment use increases in the US
8. Westlake Chemical Increases Quarterly Dividend By Over 150%
9. How chronic obstructive pulmonary disease increases risk of lung cancer
10. Washingtons forests will lose stored carbon as area burned by wildfire increases
11. Weight gain induced by high-fat diet increases active-period sleep and sleep fragmentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... of the 1962 Nobel Prize with Francis Crick and Maurice ... DNA, will present "Curing Incurable Cancer" and attend other events ... the James Graham Brown Cancer Center at the University of ... 5, at the Brown Theater, 315 W. Broadway, Louisville. Admission ...
... early stages of a major cause of failure in joint ... avoid additional surgery. More than 1.5 million total joint replacement ... is 90 per cent, almost 10 per cent of implants ... journal Molecular Pharmaceutics . Dong Wang and colleagues ...
... do not rely on oxygen may have played an important ... to a theory that UChicago researcher Albert Colman is testing ... Siberia. He has found that bacteria at the site ... that scientists must take into account as they attempt to ...
Cached Biology News:UofL hosts address by Nobel Laureate, DNA structure co-discoverer James Watson 2Cold case: Siberian hot springs reveal ancient ecology 2Cold case: Siberian hot springs reveal ancient ecology 3
(Date:5/20/2015)... Mass. , May 20, 2015  Haemonetics Corporation ... Concannon , President & CEO, will present at The ... York on June 1 st , 2015 ... may access Mr. Concannon,s presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global ...
(Date:5/20/2015)... May 20, 2015  Resolution Bioscience announced today the ... ALK TM , a blood-based liquid biopsy for an ... carcinoma (NSCLC), the most common form of this cancer. ... guide patients to personalized therapies and direct them into ... The Department of Health, the CLIA authority in ...
(Date:5/20/2015)... Carolina , 20. Mai 2015 ... für klinische Logistik (Clinical Logistics Organization/CLO) ... Geschäftsjahr 2014, das am 31. Dezember ... Unternehmen hat die Marktentwicklung übertroffen und ... - http://photos.prnewswire.com/prnh/20110930/NY78064LOGO ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 The ... based not-for-profit organization, is pleased to announce they are ... Trials Day. These donations represent the effort and commitment ... at the GGI partner sites in 2014. , ... the greater good of clinical trial participation, GGI supports ...
Breaking Biology Technology:Resolution Bioscience Receives CLIA Certification for its Diagnostic Laboratory and Launches CLIA-Certified Liquid Biopsy for Lung Cancer 2Marken schließt Ergebnisse für das Geschäftsjahr 2014 ab 2The Greater Gift Initiative Donates over 10,000 Vaccines in Honor of International Clinical Trials Day 2
... immunoaffinity purified antibody detects an ~185 kDa ... of ErbB-2 phosphorylated at tyrosine 1248 on ... been cross adsorbed against the non-phosphorylated peptide ... non-phosphorylated form of the protein. In ...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
...
... The complete SSCP kit provides all ... mutation detection by single-stranded conformation polymorphism analysis ... system. The kit includes a cooling finger ... (not provided), 2 sets of 20 cm ...
Biology Products: